Skip to main content

Pay Bill Portals

Our Tests
Our Services
- - Oncology
    - - SERVICES
        
        NateraCore Services
        
        Pharma Partnership
    - - FOR PATIENTS
        
        Schedule Session with Patient Coordinator
        
        Pricing and Billing Information
        
        Contact Us
    - - FOR CLINICIANS
        
        Schedule Session With Client Services
        
        Oncology Portal
        
        Order a Test Kit
        
        Contact Us
  - Organ Health
    - - SERVICES
        
        NateraCore Services
        
        ProReach
    - - FOR PATIENTS
        
        Schedule a Genetic Information Session
        
        Contact Us
    - - FOR CLINCIANS
        
        Organ Health Portal
        
        Contact Us
  - Women’s Health
    - - SERVICES
        
        NateraCore Services
        
        Constellation
    - - FOR PATIENTS
        
        Schedule a Genetic Information Session
        
        Pricing and Billing Information
        
        Women’s Health Portal
        
        Contact Us
    - - FOR CLINICIANS
        
        Order Tests and Track Status on NateraConnect
        
        View Patient Results on NateraConnect
        
        Contact Us
Patient Resources
- - Oncology
    - - LEARN
        
        Blog
        
        Brochures
        
        Manuals
        
        Studies
        
        Videos
        
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule Blood Draw (Existing Patients)
        
        Schedule Session with Patient Coordinator
        
        Pricing and Billing Information
    - - CONNECT
        
        Contact Us
  - Organ Health
    - - LEARN
        
        Brochures
        
        Manuals
        
        Podcasts
        
        Reports
        
        Studies
        
        Videos
        
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule Blood Draw (Existing Patients)
        
        Schedule a Genetic Information Session
    - - CONNECT
        
        Contact Us
  - Women’s Health
    - - LEARN
        
        Blog
        
        Brochures
        
        Manuals
        
        Videos
        
        Webinars
        
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule a Genetic Information Session
        
        Schedule Blood Draw (Existing Patients)
        
        Pricing and Billing Information
        
        Women’s Health Portal
    - - CONNECT
        
        Contact Us
Clinical Resources
- - Oncology
    - - CLINICAL RESOURCES
        
        Blog
        
        Manuals
        
        Peer-reviewed Publications
        
        Posters
        
        Reports
        
        Videos
        
        Whitepapers
        
        View All Clinician Resources
    - - RESEARCH STUDIES
        
        Signatera Research Pipeline
        
        BESPOKE CRC
        
        BESPOKE IO
    - - CONNECT
        
        Oncology Portal
        
        Contact Us
  - Organ Health
    - - CLINICAL RESOURCES
        
        Brochures
        
        Manuals
        
        Peer-reviewed Publications
        
        Podcasts
        
        Reports
        
        Studies
        
        Videos
        
        Webinars
        
        View All Clinician Resources
    - - RESEARCH STUDIES
        
        ProActive Study
        
        PEDAL Study
        
        Trifecta Study
        
        MOTR Study
    - - CONNECT
        
        Organ Health Portal
        
        Contact Us
  - Women’s Health
    - - CLINICAL RESOURCES
        
        Blog
        
        Brochures
        
        Manuals
        
        Peer-reviewed Publications
        
        Webinars
        
        Videos
        
        Natera Academy Provider Education Hub
        
        View All Clinician Resources
    - - RESEARCH STUDIES
    - - CONNECT
        
        Contact Us
Company
Search for:
Pay Bill

Portals
Search for:

Natera, Inc.

- Altera
- Anora
- Empower
- Horizon
- Panorama
- Prospera
- Renasight
- Signatera
- Spectrum
- Vistara
- Blog
- Videos
- Brochure
- Whitepaper
- Manual
- Poster
- Report
- Study
- Webinars
- Natera Academy

Recent Searches

Home
Signatera
SGO 2023 - Post-surgical ctDNA-based Molecular Residual Disease Detection in Patients with Stage I Endometrial Malignancies

SGO 2023 - Post-surgical ctDNA-based Molecular Residual Disease Detection in Patients with Stage I Endometrial Malignancies

Published Date June 12, 2023

Fill form to unlock content

Loading, please wait

Error - something went wrong!

Please complete the form to access this presentation.

Thank you!

View Presentation

Previous Article

Powering Precision: The essential role of ctDNA testing for MRD assessment in GI malignancies

In this webinar, we explore how ctDNA can help bring clarity to common clinical scenarios including adjuvant treatment decision making, indeterminate findings and assessing treatment response.
Next Resource

SGO 2023 - Immunotherapy response monitoring using personalized circulating tumor DNA analysis

Related Content

4 days ago
Natera Product Brochure

Read More
5 days ago
IMvigor010: Demonstrating the predictive value of ctDNA in the post-surgical setting

Read More
17 days ago
Panel Discussion: How ctDNA Testing is Informing the Management of Patients With GI Cancer

Our experts will review real-world case studies showing when and where ctDNA can help inform shared decision-making.

Watch Video
24 days ago
Feasibility of Longitudinal ctDNA Assessment in Patients with Uterine and Extra-Uterine Leiomyosarcoma

Zhou M, Bui N, Rathore R, et al. Cancers. 2023

Read More
24 days ago
Early Relapse Detection and Monitoring Disease Status in Patients with Early-stage Pancreatic Adenocarcinoma using Circulating Tumor DNA

Abdelrahim M, Esmail A, Xu J, et al. J Surg Res. 2021

Read More
24 days ago
Reply to F. Dayyani et al

Kasi PM, Fehringer G, Aleshin A, et al. JCO Precision Oncology no. 6 (2022)

Read More
24 days ago
Spontaneous Fluctuations of Tumor-Informed Circulating Tumor DNA at Low Levels

Dayyani F, Senthil M. JCO Precision Oncology no. 6 (2022)

Read More
24 days ago
Impact of Circulating Tumor DNA–Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors

Kasi P, Fehringer G, Taniguchi H, et al. JCO-PO. 2022

Read More
24 days ago
The Utility of Circulating Tumor DNA (ctDNA) Monitoring in Cancer Patients Who Are Pregnant or Planning to Become Pregnant

Cohen SA, Kasi A, Hook N, et al. Case Reports in Obstetrics and Gynecology. 2022

Read More
24 days ago
BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients wit

Kasi PM, Chakrabarti S, Sawyer S, et al. BMJ Open. 2022

Read More
24 days ago
Practical recommendations for using ctDNA in clinical decision making

Cohen S, Liu MC, Aleshin A. Nature. 2023

Read More
24 days ago
Assessment of Molecular Residual Disease Using Circulating Tumor DNA to Identify Multiple Myeloma Patients at High Risk of Relapse

Dhakal B, Sharma S, Balcioglu M et al. Front. in Oncol. 2022

Read More
24 days ago
Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient

Yeakel J, Kannan A, Rattigan NH, et al. JAAD Case Report

Read More
24 days ago
Circulating tumor DNA as a predictive biomarker in Merkel cell carcinoma

Park S J, Kannan A, Harris JP NH, et al. AAD Case Report

Read More
24 days ago
Case report: Real-world experience using a personalized cancer-specific circulating tumor DNA assay in different metastatic melanoma scenari

Khaddour K, Zhou A, Butt OH, et al. Front. Oncol. 2022

Read More
24 days ago
Feasibility of Personalized ctDNA Detection in Stage II and III Melanoma

Brunsgaard EK, Bowles TL, Asare EA, et al. Melanoma Res. 2023

Read More
24 days ago
Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase 2 NeoCOAST Platform Trial

Cascone T, Kar G, Spicer JD, et al. Cancer Discov. 2023

Read More
24 days ago
Longitudinal Monitoring of Circulating Tumor DNA to Assess the Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Genitourin

Jang A, Lanka SM, Jaeger EB, et al. JCO Precis Oncol 2023

Read More
24 days ago
Utility of tumor-informed circulating tumor DNA in the clinical management of gastrointestinal malignancies

Zhang S, Brazel D, Kumar P, et al. Gastrointestinal Oncology. 2021

Read More
24 days ago
Reply to S. Chakrabarti and A. Mahipal

Reply to S. Chakrabarti et al. JCO-Precision Oncology. 2023

Read More

Return to Resource Library

© Natera, Inc.

Our Tests
Our Services
Patient Resources
Clinical Resources
- Resource Library
- Provider Portals
Company
Contact

Natera Licenses
IT Security Compliance
Natera Notice of Data Collection for California Residents
Privacy Practices
Privacy Policy
Terms of Use
Sitemap

The tests described have been developed and their performance characteristics determined by the CLIA-certified laboratory performing the test. The tests have not been cleared or approved by the US Food and Drug Administration (FDA). Although FDA is exercising enforcement discretion of premarket review and other regulations for laboratory-developed tests in the US, certification of the laboratory is required under CLIA to ensure the quality and validity of the tests. CAP accredited, ISO 13485 certified, and CLIA certified. © 2023 Natera, Inc. All Rights Reserved.